- Overview
- Modules
- Pricing
- FAQs
May 2025 - May 2026
Apr 2026 - May 2027
4 000 kr. off with PROMO CODE ND-4000
Broaden Your Perspectives on Veterinary Oncology Online
Oncology is rapidly becoming a key field in small animal practice. With the rise in oncology patients and advanced treatments, veterinary professionals are increasingly adopting innovative approaches to cancer care. Our General Practitioner Certificate (GPCert) Postgraduate Program in Oncology is designed to provide you with the latest knowledge in compassionate, state-of-the-art cancer care, ensuring you deliver safe and comprehensive diagnostics and treatments.
Advance Your Skills in a Structured and Logical Manner
This online learning program is meticulously structured to cover the main concepts of oncological diseases. It starts with an in-depth understanding of cancer biology and progresses through the latest information on diagnosis, staging, and therapy. Interactive case management sessions help consolidate this knowledge.
Key topics include:
- Diagnostic imaging techniques
- Cytology and laboratory diagnosis
- Common types of cancer in small animals
- Treatment options such as surgery, radiation therapy, and chemotherapy
The program consists of 12 online modules over 14 months, with each session including nine lessons, two case studies, course notes, and weekly summary videos.
Boost Your Confidence and Earn a Recognised Qualification
Led by renowned specialists, this innovative program helps you develop a clinical, evidence-based approach to achieve the best outcomes for your patients. Instead of relying on generic protocols, you'll learn to address each case individually, enhancing your confidence in investigating and treating cancer in small animals.
Enroll Now and Transform Your Veterinary Oncology Practice
Join the General Practitioner Certificate (GPCert) Postgraduate Program in Oncology to enhance your expertise and stay at the forefront of veterinary cancer care.
Key features of this program
12 varied modules
Covering key clinical subjects with clinical case discussions for a more comprehensive learning
Support and guidance from a Module Tutor who is recognised in their subject field
The specialist in the subject area will provide online support during each module and will be available to answer all your questions
Leading online learning experience
Presentations, written notes, diagrams, interactive quizzes and exercises that test your knowledge as you work
Discussion forum
A discussion forum for conversation, debate and sharing cases with your peers and Module Tutors
100% online
Giving you access 24/7 via our world-leading Learning Management Platform
Dedicated Programme Coordinator
A dedicated Programme Coordinator who will support you every step of the way
Interactive and engaging modules
Which allow you to absorb the learning materials in an online environment
Know-How
Join the global veterinary online CPD specialists and benefit from our know-how and high-quality resources
Expert Speakers
Leading experts in a variety of clinical topics delivering the latest content and who will guide you throughout the programme
Programme Details
Module Summary
- Cancer biology
- Diagnostic imaging of the oncology patient
- Cytology and laboratory diagnosis of the oncology patient
- Treatment of cancer: surgery, radiation therapy and chemotherapy
- Lymphoma, leukaemia, myeloma
- Mast cell tumours
- Other skin tumours and soft tissue sarcomas
- Urogenital tumours and mammary tumours
- Skeletal and respiratory tumours
- Oral and gastrointestinal tumours
- Splenic tumours, haemangiosarcoma and histiocytic sarcoma
- Endocrine, neurological and ocular tumours
Please note the module order may be subject to change
Qualifications
Our Oncology Online Learning Program offers a comprehensive array of structured learning with the ultimate flexibility, allowing you to access the training you need while managing your busy practice life.
You can gain new knowledge and skills to apply in your practice, or work towards earning a recognised qualification.
The Oncology Online Learning program is provided by Improve Veterinary Education in collaboration with the International School of Veterinary Postgraduate Studies (ISVPS).
Complete all modules and be eligible to apply for the General Practitioner Certificate (GPCert) by purchasing and passing the required assessments with the International School of Veterinary Postgraduate Studies (ISVPS).
NOTE: Dates displayed on this program are subject to change.
Speakers
GPCert in Oncology
Get in touch
Accredited by
01 - Cancer biology
-
Define the hallmarks of cancer
-
Explain how genetic and epigenetic changes contribute to a cancer
-
Explain how environmental effects can contribute to a cancer
-
Describe specific examples of cancers in veterinary patients caused by chronic inflammation and viral infection
-
Compare and contrast the differences between the vasculature, immune surveillance and cellular energetics between tumour tissue and benign tissue
-
List the steps in the metastatic process
-
Describe the pathophysiology behind common paraneoplastic diseases
-
Describe common histopathological parameters involved in the grading of malignancies and give examples of grading systems for common cancers
-
Compare and contrast staging methods for round cell tumours, carcinomas and sarcomas
-
Give examples of different types of pain associated with cancer and give examples of how different types of pain can be managed pharmacologically
-
Define cancer cachexia and outline treatments to ameliorate it
02 - Diagnostic imaging of the oncology patient
-
Describe how to take high quality radiographs of the thorax, limbs and oral cavity in the diagnosis and staging of cancer
-
Explain the benefits given by computed tomography over conventional radiography in the diagnosis and staging of cancer
-
Describe what sentinel lymph node mapping is, and why it is beneficial
-
Compare and contrast the use abdominal ultrasonography to abdominal computed tomography in the staging of cancer
-
Compare and contrast the needs of staging solid tumours from round cell tumours
-
Compare and contrast different techniques for identifying cancer infiltration in liver and spleen
-
Give examples of risks or complications from the use of image-guided fine needle aspiration or biopsy
-
Describe optimal combinations of imaging modalities for the staging of different cancers
-
Describe the basics of interpreting MR images in the diagnosis of CNS neoplasia
-
Outline the benefit of techniques for example PET-CT over conventional contrast CT scanning
03 - Cytology and laboratory diagnosis of the oncology patient
-
Explain how to identify whether a cytology sample is of adequate diagnostic quality
-
Describe cellular features of malignancy in the context of the cells in question
-
Be able to identify the cytological appearance of common benign and malignant skin tumours
-
Be able to identify mast cell tumours cytologically and comment on their degree of cellular differentiation
-
Explain the criteria for classifying a lymph node cytology smear as “lymphoma” versus “reactive hyperplasia”
-
Describe the use of different fine needle aspiration techniques to obtain diagnostic samples from different tumours
-
Explain the criteria used for the cytological diagnosis of a sarcoma and comment on features which may differentiate the type of sarcoma
-
Explain the cytological features of common carcinomas
-
Explain how flow cytometry works and why it is of value in the diagnosis of lymphoid malignancies
-
Describe examples of different PCR-based tests available for diagnosis of canine cancers and comment on the limitations of these tests
04 - Treatment of cancer: surgery, radiation therapy and chemotherapy
-
Outline the limitations and complications possible with surgical or needle-core biopsy of solid tumours
-
Describe, compare and contrast different methods for assessing completeness of excision
-
Explain the difference between palliative and definitive radiation therapy, and give examples of cancers appropriate for each
-
Explain the 4 Rs of radiation therapy
-
Explain the difference between acute and delayed adverse effects of radiation therapy
-
Describe the principles and limitations of maximum tolerated dose chemotherapy
-
Describe the principles and limitations of metronomic chemotherapy
-
Describe the principles and limitations of small molecule inhibition
-
Give examples of the use of immunotherapy in veterinary oncology and the challenges it faces
-
Discuss pertinent considerations in counselling of a client whose pet is being considered for chemotherapy treatment
05 - Lymphoma, leukaemia, myeloma
-
Compare and contrast the presentation of lymphoma in cats and dogs
-
Describe the means of diagnosis of lymphoma
-
Compare and contrast the utility of diagnostic tests to confirm or subtype lymphoma between dogs and cats
-
Explain the value of the information gained from staging a case of lymphoma
-
Describe important prognostic factors for canine and feline lymphoma
-
Describe appropriate treatments and prognoses for different types of canine lymphoma
-
Describe appropriate treatment for different presentations of feline lymphoma
-
Discuss the evidence base for the treatment of canine indolent lymphomas
-
Describe prognostic factors and treatment for chronic and acute lymphoid leukaemias in dogs and cats
-
Describe the presentation, diagnosis, and treatment for multiple myeloma in dogs and cats
06 - Mast cell tumours
-
List important prognostic factors for canine mast cell tumours, from history, physical examination and histopathology
-
Discuss the relative independence of one prognostic factor versus another, and outline the strongest indicators of prognosis
-
Explain how to use immunohistochemical labelling appropriately
-
Describe practical methods of staging mast cell tumours depending on their location on the body
-
Describe appropriate use of surgical treatment for a mast cell tumour
-
Describe options for treatment of an incomplete surgical excision
-
Explain when to use chemotherapy for mast cell tumours
-
Explain when to use tyrosine kinase inhibitors for mast cell tumours
-
Describe appropriate circumstances for the use of intralesional tigilanol tiglate.
-
Explain prognostic factors and outline treatment for feline cutaneous, intestinal and visceral mast cell tumours
07 - Other skin tumours and soft tissue sarcomas
-
Explain a pragmatic approach to the investigation and treatment of cutaneous and subcutaneous masses in dogs
-
Describe the prognostic factors for soft tissue sarcomas
- Describe the surgical approach to canine soft tissue sarcomas
-
List the options for treatment of soft tissue sarcomas where excision with appropriate margins is not possible
-
List the options for treatment of soft tissue sarcomas where surgical excision is incomplete
-
Describe appropriate chemotherapy treatments for metastatic or high-grade soft tissue sarcomas
-
Describe the causal factors and clinical presentation of feline injection site sarcomas
-
Explain how and when to investigate a cutaneous / subcutaneous mass on a cat
-
Describe appropriate treatment of a feline injection site sarcoma
-
Describe appropriate means of minimizing the risk of feline injection site sarcomas
08 - Urogenital tumours and mammary tumours
-
Describe important risk factors for the developing of a canine transitional cell carcinoma (TCC)
-
Describe means of diagnosis of a canine TCC (and the associated limitations)
-
Describe the behaviour and prognosis for canine TCCs
-
Describe appropriate treatments for canine TCCs
-
Explain the differences between canine and feline TCCs
-
Explain important causal factors in the development of a canine prostate tumour
-
Outline the biology, treatment and prognosis of the transmissible venereal tumour
-
Describe the prognostic factors for canine mammary tumours and outline the strongest prognostic factors
-
Describe the prognosis for feline mammary tumours and outline the strongest prognostic factors
-
Explain the evidence base for the medical treatment of canine and feline mammary tumours
09 - Skeletal and respiratory tumours
-
Describe the radiographic features of aggressive bone lesions in dogs and cats
-
Describe safe and pragmatic techniques of investigating aggressive bone lesions in dogs and cats
-
Describe the prognostic factors, staging and treatment of canine osteosarcoma
-
Compare and contrast the difference in behaviour and treatment between canine osteosarcoma, histiocytic sarcoma and other sarcomas of bone.
-
Compare and contrast the radiographic features, behaviour, treatment and prognosis between canine and feline osteosarcoma
-
Describe the key differential diagnoses and prognostic factors for canine and feline sinonasal tumours.
-
List appropriate steps in the investigation and treatment of sinonasal tumours
-
Describe prognostic factors and differential diagnoses for pulmonary tumours
-
Describe appropriate management of canine and feline pulmonary tumours
-
Outline the behaviour, prognosis and treatment of thymomas in cats and dogs
10 - Oral and gastrointestinal tumours
-
Outline the important differential diagnoses for oral tumours in dogs and in cats
-
Describe an appropriate and pragmatic investigation for an oral mass
-
Describe treatment options and treatment options for common oral tumours in dogs and cats
-
Outline the important differential diagnoses for gastrointestinal and hepatobiliary tumours in dogs and in cats
-
Describe an appropriate and pragmatic investigation for a gastrointestinal or hepatobiliary tumour
-
Describe treatment options and treatment options for common gastrointestinal or hepatobiliary tumours in dogs and cats
-
Describe the epidemiology, clinical presentation and investigation of anal gland and perianal tumours in dogs
-
List important prognostic factors for anal gland tumours in dogs
-
Describe treatment options for both advanced and early anal gland tumours in dogs
11 - Splenic tumours, haemangiosarcoma and histiocytic sarcoma
-
Explain methods of predicting the diagnosis of a splenic mass based on signalment and clinical presentation, and the accuracy of these techniques
-
Describe pragmatic approach to spontaneous haemoabdomen in dogs
-
Outline the differential diagnoses and prognosis for spontaneous haemoabdomen in cats
-
Explain the pathology of haemangiosarcoma, in relation to its behaviour and paraneoplastic disease
-
Describe prognostic factors for canine haemangiosarcoma
-
Describe appropriate treatments for canine haemangiosarcoma, with and without gross disease
-
Describe the biology, pathophysiology, epidemiology and prognostic factors for canine
-
Describe appropriate treatments for different presentation of histiocytic sarcoma
-
Outline the management of less-common splenic malignancies
12 - Endocrine, neurological and ocular tumours
-
Describe the pathophysiology of common tumour-related endocrinopathies of the adrenal, pituitary, thyroid, parathyroid glands and beta cells of the pancreas
-
Choose appropriate diagnostic tests for the diagnosis of the above endocrinopathies
-
Describe appropriate management of the above endocrinopathies
-
Outline definitive treatment for the above tumour-related endocrinopathies
-
Describe the clinical presentation, pathologies, and imaging findings in different neurological tumours
-
List the challenges in the diagnosis of neurological tumours
-
Describe the treatment options for neurological tumours and the factors which influence response to treatment
-
Outline important benign and malignant ocular tumours
-
Describe treatment options and prognosis for ocular tumours
Venue: Online
Date: May 2025 - May 2026
GPCert in Oncology
Get in touch
Accredited by
01 - Cancer biology
-
Define the hallmarks of cancer
-
Explain how genetic and epigenetic changes contribute to a cancer
-
Explain how environmental effects can contribute to a cancer
-
Describe specific examples of cancers in veterinary patients caused by chronic inflammation and viral infection
-
Compare and contrast the differences between the vasculature, immune surveillance and cellular energetics between tumour tissue and benign tissue
-
List the steps in the metastatic process
-
Describe the pathophysiology behind common paraneoplastic diseases
-
Describe common histopathological parameters involved in the grading of malignancies and give examples of grading systems for common cancers
-
Compare and contrast staging methods for round cell tumours, carcinomas and sarcomas
-
Give examples of different types of pain associated with cancer and give examples of how different types of pain can be managed pharmacologically
-
Define cancer cachexia and outline treatments to ameliorate it
02 - Diagnostic imaging of the oncology patient
-
Describe how to take high quality radiographs of the thorax, limbs and oral cavity in the diagnosis and staging of cancer
-
Explain the benefits given by computed tomography over conventional radiography in the diagnosis and staging of cancer
-
Describe what sentinel lymph node mapping is, and why it is beneficial
-
Compare and contrast the use abdominal ultrasonography to abdominal computed tomography in the staging of cancer
-
Compare and contrast the needs of staging solid tumours from round cell tumours
-
Compare and contrast different techniques for identifying cancer infiltration in liver and spleen
-
Give examples of risks or complications from the use of image-guided fine needle aspiration or biopsy
-
Describe optimal combinations of imaging modalities for the staging of different cancers
-
Describe the basics of interpreting MR images in the diagnosis of CNS neoplasia
-
Outline the benefit of techniques for example PET-CT over conventional contrast CT scanning
03 - Cytology and laboratory diagnosis of the oncology patient
-
Explain how to identify whether a cytology sample is of adequate diagnostic quality
-
Describe cellular features of malignancy in the context of the cells in question
-
Be able to identify the cytological appearance of common benign and malignant skin tumours
-
Be able to identify mast cell tumours cytologically and comment on their degree of cellular differentiation
-
Explain the criteria for classifying a lymph node cytology smear as “lymphoma” versus “reactive hyperplasia”
-
Describe the use of different fine needle aspiration techniques to obtain diagnostic samples from different tumours
-
Explain the criteria used for the cytological diagnosis of a sarcoma and comment on features which may differentiate the type of sarcoma
-
Explain the cytological features of common carcinomas
-
Explain how flow cytometry works and why it is of value in the diagnosis of lymphoid malignancies
-
Describe examples of different PCR-based tests available for diagnosis of canine cancers and comment on the limitations of these tests
04 - Treatment of cancer: surgery, radiation therapy and chemotherapy
-
Outline the limitations and complications possible with surgical or needle-core biopsy of solid tumours
-
Describe, compare and contrast different methods for assessing completeness of excision
-
Explain the difference between palliative and definitive radiation therapy, and give examples of cancers appropriate for each
-
Explain the 4 Rs of radiation therapy
-
Explain the difference between acute and delayed adverse effects of radiation therapy
-
Describe the principles and limitations of maximum tolerated dose chemotherapy
-
Describe the principles and limitations of metronomic chemotherapy
-
Describe the principles and limitations of small molecule inhibition
-
Give examples of the use of immunotherapy in veterinary oncology and the challenges it faces
-
Discuss pertinent considerations in counselling of a client whose pet is being considered for chemotherapy treatment
05 - Lymphoma, leukaemia, myeloma
-
Compare and contrast the presentation of lymphoma in cats and dogs
-
Describe the means of diagnosis of lymphoma
-
Compare and contrast the utility of diagnostic tests to confirm or subtype lymphoma between dogs and cats
-
Explain the value of the information gained from staging a case of lymphoma
-
Describe important prognostic factors for canine and feline lymphoma
-
Describe appropriate treatments and prognoses for different types of canine lymphoma
-
Describe appropriate treatment for different presentations of feline lymphoma
-
Discuss the evidence base for the treatment of canine indolent lymphomas
-
Describe prognostic factors and treatment for chronic and acute lymphoid leukaemias in dogs and cats
-
Describe the presentation, diagnosis, and treatment for multiple myeloma in dogs and cats
06 - Mast cell tumours
-
List important prognostic factors for canine mast cell tumours, from history, physical examination and histopathology
-
Discuss the relative independence of one prognostic factor versus another, and outline the strongest indicators of prognosis
-
Explain how to use immunohistochemical labelling appropriately
-
Describe practical methods of staging mast cell tumours depending on their location on the body
-
Describe appropriate use of surgical treatment for a mast cell tumour
-
Describe options for treatment of an incomplete surgical excision
-
Explain when to use chemotherapy for mast cell tumours
-
Explain when to use tyrosine kinase inhibitors for mast cell tumours
-
Describe appropriate circumstances for the use of intralesional tigilanol tiglate.
-
Explain prognostic factors and outline treatment for feline cutaneous, intestinal and visceral mast cell tumours
07 - Other skin tumours and soft tissue sarcomas
-
Explain a pragmatic approach to the investigation and treatment of cutaneous and subcutaneous masses in dogs
-
Describe the prognostic factors for soft tissue sarcomas
- Describe the surgical approach to canine soft tissue sarcomas
-
List the options for treatment of soft tissue sarcomas where excision with appropriate margins is not possible
-
List the options for treatment of soft tissue sarcomas where surgical excision is incomplete
-
Describe appropriate chemotherapy treatments for metastatic or high-grade soft tissue sarcomas
-
Describe the causal factors and clinical presentation of feline injection site sarcomas
-
Explain how and when to investigate a cutaneous / subcutaneous mass on a cat
-
Describe appropriate treatment of a feline injection site sarcoma
-
Describe appropriate means of minimizing the risk of feline injection site sarcomas
08 - Urogenital tumours and mammary tumours
-
Describe important risk factors for the developing of a canine transitional cell carcinoma (TCC)
-
Describe means of diagnosis of a canine TCC (and the associated limitations)
-
Describe the behaviour and prognosis for canine TCCs
-
Describe appropriate treatments for canine TCCs
-
Explain the differences between canine and feline TCCs
-
Explain important causal factors in the development of a canine prostate tumour
-
Outline the biology, treatment and prognosis of the transmissible venereal tumour
-
Describe the prognostic factors for canine mammary tumours and outline the strongest prognostic factors
-
Describe the prognosis for feline mammary tumours and outline the strongest prognostic factors
-
Explain the evidence base for the medical treatment of canine and feline mammary tumours
09 - Skeletal and respiratory tumours
-
Describe the radiographic features of aggressive bone lesions in dogs and cats
-
Describe safe and pragmatic techniques of investigating aggressive bone lesions in dogs and cats
-
Describe the prognostic factors, staging and treatment of canine osteosarcoma
-
Compare and contrast the difference in behaviour and treatment between canine osteosarcoma, histiocytic sarcoma and other sarcomas of bone.
-
Compare and contrast the radiographic features, behaviour, treatment and prognosis between canine and feline osteosarcoma
-
Describe the key differential diagnoses and prognostic factors for canine and feline sinonasal tumours.
-
List appropriate steps in the investigation and treatment of sinonasal tumours
-
Describe prognostic factors and differential diagnoses for pulmonary tumours
-
Describe appropriate management of canine and feline pulmonary tumours
-
Outline the behaviour, prognosis and treatment of thymomas in cats and dogs
10 - Oral and gastrointestinal tumours
-
Outline the important differential diagnoses for oral tumours in dogs and in cats
-
Describe an appropriate and pragmatic investigation for an oral mass
-
Describe treatment options and treatment options for common oral tumours in dogs and cats
-
Outline the important differential diagnoses for gastrointestinal and hepatobiliary tumours in dogs and in cats
-
Describe an appropriate and pragmatic investigation for a gastrointestinal or hepatobiliary tumour
-
Describe treatment options and treatment options for common gastrointestinal or hepatobiliary tumours in dogs and cats
-
Describe the epidemiology, clinical presentation and investigation of anal gland and perianal tumours in dogs
-
List important prognostic factors for anal gland tumours in dogs
-
Describe treatment options for both advanced and early anal gland tumours in dogs
11 - Splenic tumours, haemangiosarcoma and histiocytic sarcoma
-
Explain methods of predicting the diagnosis of a splenic mass based on signalment and clinical presentation, and the accuracy of these techniques
-
Describe pragmatic approach to spontaneous haemoabdomen in dogs
-
Outline the differential diagnoses and prognosis for spontaneous haemoabdomen in cats
-
Explain the pathology of haemangiosarcoma, in relation to its behaviour and paraneoplastic disease
-
Describe prognostic factors for canine haemangiosarcoma
-
Describe appropriate treatments for canine haemangiosarcoma, with and without gross disease
-
Describe the biology, pathophysiology, epidemiology and prognostic factors for canine
-
Describe appropriate treatments for different presentation of histiocytic sarcoma
-
Outline the management of less-common splenic malignancies
12 - Endocrine, neurological and ocular tumours
-
Describe the pathophysiology of common tumour-related endocrinopathies of the adrenal, pituitary, thyroid, parathyroid glands and beta cells of the pancreas
-
Choose appropriate diagnostic tests for the diagnosis of the above endocrinopathies
-
Describe appropriate management of the above endocrinopathies
-
Outline definitive treatment for the above tumour-related endocrinopathies
-
Describe the clinical presentation, pathologies, and imaging findings in different neurological tumours
-
List the challenges in the diagnosis of neurological tumours
-
Describe the treatment options for neurological tumours and the factors which influence response to treatment
-
Outline important benign and malignant ocular tumours
-
Describe treatment options and prognosis for ocular tumours
Venue: Online
Date: Apr 2026 - May 2027
GPCert in Oncology
Get in touch
Accredited by
4 000 kr. off with PROMO CODE ND-4000
Pricing Billing
Oncology
| Payment Option | First Payment | Second Payment(s) | Total Payment |
|---|
The fees include ALL registration and exam fees to achieve a GPCert from ISVPS.
Payment Terms & Conditions
1. In order to confirm your place, we must receive payment in full or the relevant initial payment.
2. Please also see our full terms and conditions on our website – Terms and Conditions.
Registration Information
1. Applications are accepted on a first-come, first served basis.
2. Where all available places are full, applicants will be offered first refusal for the next available date.
3. Improve International reserves the right to close the intake early if the number of applications received exceeds the number of available places.
4. Confirmation and enrolment details will then be sent to applicants once we have received a completed application form.
Venue: Online
Date: May 2025 - May 2026
GPCert in Oncology
Get in touch
Accredited by
4 000 kr. off with PROMO CODE ND-4000
Pricing Billing
Oncology
| Payment Option | First Payment | Second Payment(s) | Total Payment |
|---|
The fees include ALL registration and exam fees to achieve a GPCert from ISVPS.
Payment Terms & Conditions
1. In order to confirm your place, we must receive payment in full or the relevant initial payment.
2. Please also see our full terms and conditions on our website – Terms and Conditions.
Registration Information
1. Applications are accepted on a first-come, first served basis.
2. Where all available places are full, applicants will be offered first refusal for the next available date.
3. Improve International reserves the right to close the intake early if the number of applications received exceeds the number of available places.
4. Confirmation and enrolment details will then be sent to applicants once we have received a completed application form.
Venue: Online
Date: Apr 2026 - May 2027
GPCert in Oncology
Get in touch
Accredited by
Frequently Asked Questions
Vet Online Learning
When is the learning content available for each module?
- Module content is hosted on our Learning Management System
- At the beginning of the month, the content for weeks 1 and 2 will be released
- At the beginning of the 3rd week of the month, the remaining content will be released
- Access to our world-leading Learning Management System will be provided for a period of one year after the last day of the programme
When do the exams take place?
For up to date exam dates please visit www.isvps.org
What additional learning resources are available?
- Online interactive lessons
- Notes to support every lesson
- Pre- and post-module questions
- Summary videos at the end of each week
- Reading list
- Discussion Forum
- Module Tutor (diploma holder in their field)
- Programme Tutor support
How many hours per week will I have to spend on the programme?
You will spend on average 3-4 hours per week. Preparation of assessments and revising for the final exam is additional depending on your route.
Is the General Practitioner Certificate (GPCert) all online?
Yes, the full programme to achieve the GPCert is all online with the exception of the Surgery programme which includes ten practical modules. These will be held in two locations, see the programme for further information.
What does the GPCert consist of?
The GPCert is a middle-tier qualification awarded to veterinary surgeons who successfully complete a dedicated modular training programme accredited by ISVPS and the associated ISVPS assessments. Only registered veterinary surgeons who have been qualified for a minimum of one year can apply to undertake a General Practitioner Certificate.
-
- To achieve a GPCert you must:
-
- Complete the modular training programme
- Submit a case report (number of words defined by ISVPS)
- Sit an online multiple-choice examination
- An Online Applied Knowledge Examination (OAKE)
- Sit a Case-based scenario paper (CBS)
ISVPS are responsible for the invigilation of the exam using an independent invigilation company. More details can be found here.
Who can enrol on the Online Learning programmes?
All applicants must:
- Hold a veterinary qualification
- Have spent a minimum of one year in veterinary practice
- Be on the RCVS Home Practising Register (UK-based applicants), hold a qualification that would entitle them to register as a member of the RCVS (applicants based outside the UK)
GPCert in Oncology
Get in touch
Accredited by
